ストックスクリーナーアプリを入手
13.78
4.97%
-0.72
プレマーケット:
15.11
1.33
+9.65%
Adaptive Biotechnologies Corp (ADPT) 最新ニュース
ADPT SEC FilingsAdaptive Biotechnologies 10-K, 10-Q, 8-K Forms - Stock Titan
Adaptive Biotechnologies Corporation 10-Q Report 2026: Financial Statements, Risk Factors, and Forward-Looking Statements 173031 - Minichart
Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised - Investing.com India
Transcript: Adaptive Biotechnologies Q1 2026 Earnings Conference Call - Benzinga
Earnings call transcript: Adaptive Biotechnologies Q1 2026 revenue beats forecast - Investing.com
Adaptive Biotechnologies: Q1 Earnings Snapshot - marketscreener.com
[10-Q] Adaptive Biotechnologies Corp Quarterly Earnings Report - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) lifts 2026 MRD outlook after 35% Q1 revenue growth - Stock Titan
Adaptive lifts 2026 MRD outlook after $70.9M quarter, 41% test gain - Stock Titan
MSN Money - MSN
Adaptive Biotechnologies earnings on deck after 55% revenue surge - Investing.com
Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors. - The Motley Fool
Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares - Investing.com
How The Investment Story For Adaptive Biotechnologies (ADPT) Is Shifting With New Street Assumptions - Yahoo Finance
Adaptive Biotechnologies Corp (HAM:1HM) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Adaptive Biotechnologies Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Valuation: Significantly Overvalued - GuruFocus
Adaptive Biotechnologies Corp Stock Intrinsic Values | HAM:1HM - GuruFocus
Adaptive Biotechnologies Corp Stock Historical Valuations | HAM:1HM - GuruFocus
Adaptive Biotechnologies Corp Stock Operating Data - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Adaptive Biotechnologies Corp Stock Baskets | HAM:1HM - GuruFocus
Who's Buying or Selling Adaptive Biotechnologies Corp (HAM:1HM) Stock Today? - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM)Valuation Measures & Financial Statistics - GuruFocus
Adaptive Biotechnologies Corp Stock Warning Signs - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) DCF Valuation - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Stock Earnings Transcripts - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Stock Price, Trades & News - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Dividend - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Stock Price & 30 Year Financial Data - GuruFocus
Adaptive Biotechnologies Corp (HAM:1HM) Stock News, Headlines & Updates - GuruFocus
Adaptive Biotechnologies COO Julie Rubinstein sells $270k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies COO Julie Rubinstein sells $270k in stock - Investing.com
Adaptive Biotechnologies (ADPT) exec trades shares under Rule 10b5-1 plan - Stock Titan
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means - AOL.com
Adaptive Biotechnologies COO Julie Rubinstein sells $798k in stock By Investing.com - Investing.com Australia
Time To Buy? Stock Analysis: NIO, XPeng XPEV, Costco, Adaptive Biotechnologies ADPT, GE (JtamyA8uVU) - Fathom Journal
Adaptive Biotechnologies COO Julie Rubinstein sells $798k in stock - Investing.com
Adaptive Biotechnologies (ADPT) president sells 57K shares, exercises options - Stock Titan
[ARS] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) 2026 proxy details and 2025 performance - Stock Titan
Adaptive Biotechnologies COO Julie Rubinstein sells $1.01m in stock By Investing.com - Investing.com India
Adaptive Biotechnologies COO Julie Rubinstein sells $1.01m in stock - Investing.com
Adaptive Biotechnologies (ADPT) COO sells shares, exercises options under 10b5-1 plan - Stock Titan
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? - AOL.com
Julie Rubinstein Sells 57,180 Shares of Adaptive Biotechnologies - Intellectia AI
Adaptive Biotechnologies: Strong Sequencing, Weak Margin Of Safety (NASDAQ:ADPT) - Seeking Alpha
Is Adaptive Bio (ADPT) stock stronger than peers (Investor Interest) 2026-04-18Investment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Adaptive Biotechnologies Hits Day Low of $13.37 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies president Rubinstein sells $826k in ADPT stock By Investing.com - Investing.com UK
1.63%
0.34%
大文字化:
|
ボリューム (24 時間):